P PEPGEN INC
| Market Cap | $119.57M |
| P/E Ratio | — |
| Forward P/E | -1.49 |
| Dividend Yield | — |
| Beta | 2.34 |
| 52W Range | $1.00 - $7.17 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Viking Global Investors Viking Global Investors | 0.06% | $22.67M | 3,482,434 | — |
Insider Trading
| Insider Name of the company insider who made the trade 12 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Donnelly NoelChief Financial Officer | Sale | 2,032 | $6.23 | $12.66K | 04 Mar 2026 | 06 Mar 2026 |
| McArthur James GPresident and CEO | Sale | 131 | $6.33 | $828.58 | 04 Mar 2026 | 06 Mar 2026 |
| Donnelly NoelChief Financial Officer | Sale | 52 | $6.33 | $328.9 | 04 Mar 2026 | 06 Mar 2026 |
| STRECK PAULEVP, Head of R&D | Sale | 47 | $6.29 | $295.54 | 04 Mar 2026 | 06 Mar 2026 |
| STRECK PAULEVP, Head of R&D | Sale | 1,832 | $6.23 | $11.41K | 04 Mar 2026 | 06 Mar 2026 |
| McArthur James GPresident and CEO | Sale | 5,144 | $6.23 | $32.05K | 04 Mar 2026 | 06 Mar 2026 |
| Noel DonnellyChief Financial Officer | Sale | 52 | $6.33 | $328.9 | 04 Mar 2026 | 06 Mar 2026 |
| Noel DonnellyChief Financial Officer | Sale | 2,032 | $6.23 | $12.66K | 04 Mar 2026 | 06 Mar 2026 |
| James G McarthurPresident and CEO | Sale | 5,144 | $6.23 | $32.05K | 04 Mar 2026 | 06 Mar 2026 |
| Paul StreckEVP, Head of R&D | Sale | 47 | $6.29 | $295.54 | 04 Mar 2026 | 06 Mar 2026 |
| Paul StreckEVP, Head of R&D | Sale | 1,832 | $6.23 | $11.41K | 04 Mar 2026 | 06 Mar 2026 |
| James G McarthurPresident and CEO | Sale | 131 | $6.33 | $828.58 | 04 Mar 2026 | 06 Mar 2026 |
Frequently Asked Questions
What is PEPG stock price today?
PEPGEN INC (PEPG) is currently trading at $1.73. The stock has a 52-week range of $1.00 to $7.17 and a market capitalization of $119.57M.
Is PEPG a good stock to buy in 2026?
PEPGEN INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of +38.4%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling PEPG stock?
There have been 12 insider transactions for PEPG in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has PEPG stock performed over the past year?
PEPGEN INC (PEPG) has returned +38.4% over the past 12 months. The stock traded between $1.00 and $7.17 during this period, and is currently at $1.73.
Which hedge funds own PEPG (PEPGEN INC)?
1 tracked hedge funds currently hold PEPG in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is PEPG's market cap and valuation?
PEPGEN INC (PEPG) has a market capitalization of $119.57M. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is PEPG's revenue and profitability?
PEPGEN INC reported revenue of N/A with net income of N/A and a profit margin of N/A. The stock has a beta of 2.34.
What sector is PEPG in and who are its biggest institutional holders?
PEPGEN INC (PEPG) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.